AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Verrica Pharmaceuticals Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00L03BZ24
3.53▼ 0.30 (-7.83%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
3.83
Day's Range
3.40 – 3.76
52-Week Range
3.28 – 9.82
Volume
21.0K
Avg Volume
54.3K
Share Statistics
Shares Outstanding
Employees
76
Exchange
XNAS
Listed
2018-06-15
Share count as of July 31, 2026

Verrica Pharmaceuticals Inc. Common Stock (VRCA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Verrica Pharmaceuticals Inc. Common Stock (VRCA)
What is Verrica Pharmaceuticals Inc. Common Stock's Market Cap?
Verrica Pharmaceuticals Inc. Common Stock's Market Cap is $60.6M, based on as-reported figures from SEC (XBRL) filings.
What is Verrica Pharmaceuticals Inc. Common Stock's Enterprise Value?
Verrica Pharmaceuticals Inc. Common Stock's Enterprise Value is $50.8M, based on as-reported figures from SEC (XBRL) filings.
What is Verrica Pharmaceuticals Inc. Common Stock's Price / Sales?
Verrica Pharmaceuticals Inc. Common Stock's Price / Sales is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is Verrica Pharmaceuticals Inc. Common Stock's EV / Revenue?
Verrica Pharmaceuticals Inc. Common Stock's EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is Verrica Pharmaceuticals Inc. Common Stock's EV / EBITDA?
Verrica Pharmaceuticals Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Verrica Pharmaceuticals Inc. Common Stock's Revenue (TTM)?
Verrica Pharmaceuticals Inc. Common Stock's Revenue (TTM) is $30.3M, based on as-reported figures from SEC (XBRL) filings.
What is Verrica Pharmaceuticals Inc. Common Stock's Net Income (TTM)?
Verrica Pharmaceuticals Inc. Common Stock's Net Income (TTM) is -$31.2M, based on as-reported figures from SEC (XBRL) filings.
What is Verrica Pharmaceuticals Inc. Common Stock's EBITDA?
Verrica Pharmaceuticals Inc. Common Stock's EBITDA is -$28.3M, based on as-reported figures from SEC (XBRL) filings.
What is Verrica Pharmaceuticals Inc. Common Stock's Diluted EPS (TTM)?
Verrica Pharmaceuticals Inc. Common Stock's Diluted EPS (TTM) is -1.82, based on as-reported figures from SEC (XBRL) filings.
What is Verrica Pharmaceuticals Inc. Common Stock's EBITDA Margin?
Verrica Pharmaceuticals Inc. Common Stock's EBITDA Margin is -93.4%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · VRCAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue
YoY growth-53.8%+46.1%+1380.2%+905.4%
Operating expenses:
Cost of product revenue
Cost of license and collaboration revenue——
Selling, general and administrative
Research and development
Legal settlement, net of insurance recovery———
Total operating expenses
% of revenue323.4%293.4%241.2%88.7%
(Loss) income from operations
% of revenue-223.4%-193.4%-141.2%11.3%
Other expense:
Interest income
Interest expense
Change in fair value of derivative liability
Other expense
Total other expense, net
Net (loss) income
% of revenue-224.4%-192.8%-158.6%-1.9%
Net (loss) income per share, basic (in dollars per share)
Net (loss) income per share, diluted (in dollars shares)